Mirum Pharmaceuticals Inc.
MIRM | NASDAQ
$91.56
-$0.44 (-0.48%)
Sep 22, 2026, 2:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -168.06 | -22.35 | -7.38 | -4.86 | -5.76 | -4.27 |
PEG Ratio | 2.25 | 0.42 | 29.59 | -0.11 | 0.18 | -0.05 |
PS Ratio | 7.61 | 5.83 | 6.48 | 8.56 | 25.27 | n/a |
PB Ratio | 12.60 | 8.71 | 4.85 | 4.65 | 4.02 | 2.56 |
P/FCF Ratio | 72.26 | 210.57 | -13.26 | -5.48 | -3.19 | -4.94 |
P/OCF Ratio | 71.03 | 190.32 | -17.01 | -5.49 | -3.64 | -4.95 |
OCF/S Ratio | 10.71 | 3.06 | -38.07 | -155.90 | -693.69 | n/a |
Debt / Equity Ratio | 1.02 | 1.41 | 1.24 | 0.02 | 0.02 | 0.02 |
Quick Ratio | 2.55 | 2.93 | 4.19 | 2.85 | 3.88 | 12.80 |
Current Ratio | 2.67 | 3.10 | 4.45 | 2.94 | 3.91 | 12.80 |
Asset Turnover | 0.62 | 0.50 | 0.29 | 0.22 | 0.06 | n/a |
Interest Coverage | -1.54 | -6.12 | -7.23 | -8.21 | -9.86 | -311.33 |
Return on Equity | -7.42% | -38.97% | -65.72% | -95.51% | -69.87% | -60.01% |
Return on Assets | -2.77% | -13.11% | -25.27% | -38.44% | -28.50% | -42.87% |
Return on Invested Capital | -3.46% | -16.05% | -19.47% | -43.34% | -68.61% | -46.76% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 80.71% | 75.77% | 74.76% | 83.94% | 90.06% | n/a |
Net Profit Margin | -4.48% | -26.10% | -87.68% | -176.05% | -438.85% | n/a |
Pretax Profit Margin | -4.11% | -25.80% | -87.15% | -184.36% | -438.66% | n/a |
Operating Profit Margin | -4.25% | -26% | -58.57% | -170.28% | -906.12% | n/a |
FCF Margin | 10.53% | 2.77% | -48.85% | -156.26% | -793.09% | n/a |
EBITDA Margin | 3.30% | -14.54% | -73.23% | -159.42% | -341.66% | n/a |
Add to Watchlist
Select watchlists to add or remove MIRM